MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 23, 2007; DOI: 10.1124/mol.107.039461


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039461v1
72/5/1103    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watabe, M.
Right arrow Articles by Nakaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watabe, M.
Right arrow Articles by Nakaki, T.


Received for publication June 28, 2007.
Revised July 20, 2007.
Accepted for publication July 23, 2007.

Regulation of glutathione synthesis via interaction between GTRAP3-18 and EAAC1 at plasma membrane

Masahiko Watabe 1, Koji Aoyama 1, Toshio Nakaki 1*

1 Teikyo University School of Medicine

* Address correspondence to: E-mail: nakaki{at}med.teikyo-u.ac.jp

Abstract

Regulation of the cysteine transporter EAAC1 for intracellular glutathione (GSH) content was investigated using HEK293 cells as a model system. GSH content was significantly reduced by L-aspartate-{beta}-hydroxamate (50-250 µM), an inhibitor of both EAAC1 and GLT1, both of which are transporters to take up cysteine, while dihydrokainate (1-100 µM), a specific inhibitor of GLT1, failed to do so. This indicates that EAAC1 is involved in GSH content in HEK293 cells. We examined the effect of GTRAP3-18, which is capable of interacting with EAAC1. The GSH content decreased when the GTRAP3-18 protein level at the plasma membrane was increased by methyl-{beta}-cyclodextrin (250 µM), rendering the cells more vulnerable to oxidative stress. Intracellular GSH increased when the GTRAP3-18 protein level at the plasma membrane was decreased by antisense oligonucleotides, rendering the cells more resistant to oxidative stress. Furthermore, we found that the increase in GSH content produced by stimulating protein kinase C, a translocator and activator of EAAC1, was inhibited by an increase in cell surface GTRAP3-18 protein. These results show GTRAP3-18 to negatively and dominantly regulate cellular GSH content via interaction with EAAC1 at the plasma membrane.


Key words: Glutathione, Oxidative stress/antioxidants, Oxidative stress


This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Watabe, K. Aoyama, and T. Nakaki
A Dominant Role of GTRAP3-18 in Neuronal Glutathione Synthesis
J. Neurosci., September 17, 2008; 28(38): 9404 - 9413.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics